欧洲生物样本库市场预测至 2028 年 - 按产品和服务（设备、耗材、服务和软件）、样本（血液制品、人体组织、细胞系等）和应用（再生医学、生命科学研究、临床研究）
No. of Pages: 178 | Report Code: TIPRE00027966 | Category: Life Sciences
No. of Pages: 178 | Report Code: TIPRE00027966 | Category: Life Sciences
在欧洲地区意大利、西班牙、英国等国家德国、法国以及俄罗斯、瑞士等其他欧洲国家受到的影响较大。由于该地区 COVID-19 病例呈指数级增长，欧洲经济受到严重影响。西班牙、意大利、德国、法国和英国是受影响最严重的欧洲国家，死亡人数也很高。根据《国际卫生条例》，当前的冠状病毒（COVID-19）疫情已被世界卫生组织宣布为国际关注的突发公共卫生事件。生物银行在对抗 Covid-19 方面发挥了很大作用，因为它们为研究人员提供了获取样本的途径，让他们能够探索这种疾病并开发疫苗和疗法。虽然疫情给生物样本库带来了重大问题，但它也为许多其他研究领域的未来发展提供了机会。如果没有感染 Covid-19 的患者样本，就不可能让整个科学界都能获取 SARS-CoV-2 病毒的基因组，并在创纪录的时间内生产出有效的疫苗。自大流行开始以来，研究人员一直要求对这些样本进行测试，以更好地了解该病毒欺骗人类免疫系统的各种机制。
随着新的功能和技术，供应商可以吸引新客户并扩大他们在新兴市场的足迹。这一因素可能会推动欧洲生物样本库市场的发展。预计欧洲生物样本库市场在预测期内将以良好的复合年增长率增长。
Strategic insights for Europe Biobanks involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 699.13 Million |
| Market Size by 2028 | US$ 1,070.46 Million |
| Global CAGR (2021 - 2028) | 6.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品和服务
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Biobanks refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Biobanks Market is valued at US$ 699.13 Million in 2021, it is projected to reach US$ 1,070.46 Million by 2028.
As per our report Europe Biobanks Market, the market size is valued at US$ 699.13 Million in 2021, projecting it to reach US$ 1,070.46 Million by 2028. This translates to a CAGR of approximately 6.3% during the forecast period.
The Europe Biobanks Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Biobanks Market report:
The Europe Biobanks Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Biobanks Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Biobanks Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Biobanks Market
